West Pharmaceutical Services | WST - Current Liabilities



West Pharmaceutical Services reported $604.6M in Current Liabilities for its fiscal quarter ending in June of 2025.


Current Liabilities Change Date
Align Technology USD 2B 4.54M Jun/2025
Avanos Medical USD 134.6M 2.6M Jun/2025
Baxter International USD 3.48B 3.03B Mar/2025
Becton, Dickinson and Co. USD 8.16B 469M Jun/2025
Charles River Laboratories USD 1.08B 29.38M Jun/2025
Cooper Companies USD 1.01B 2.4M Jul/2025
Dentsply International USD 1.17B 627M Jun/2025
Haemonetics USD 531.41M 46.71M Jun/2025
ICU Medical USD 482.78M 66.25M Jun/2025
Insulet USD 1.01B 489.7M Jun/2025
Integra LifeSciences USD 929.81M 11.35M Jun/2025
IQVIA Holdings USD 7.57B 393M Jun/2025
J&J USD 56.9B 6.58B Mar/2025
Medtronic USD 12.88B 1.04B Apr/2025
Merit Medical Systems USD 225.57M 28.75M Jun/2025
Neogen USD 174.01M 32.81M May/2025
Quidel USD 1.14B 94.9M Jun/2025
Repligen USD 152M 25.21M Mar/2025
Solventum Corp 2.62B 54M Jun/2025
STAAR Surgical USD 59.23M 9.13M Jun/2025
Terumo JPY 271.9B 30.93B Jun/2025
West Pharmaceutical Services USD 604.6M 77.9M Jun/2025